BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32520749)

  • 21. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
    Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
    Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
    Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
    Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report.
    Mazzucchelli R; Scarpelli M; Montironi R
    J Clin Pathol; 2003 Jun; 56(6):465-7. PubMed ID: 12783975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
    Vail E; Zheng X; Zhou M; Yang X; Fallon JT; Epstein JI; Zhong M
    Ann Diagn Pathol; 2015 Oct; 19(5):301-5. PubMed ID: 26239299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
    Zaleski MP; Chen H; Roy-Chowdhuri S; Patel KP; Luthra R; Routbort MJ; Kamat AM; Gao J; Siefker-Radtke A; Czerniak B; Guo CC
    Am J Clin Pathol; 2022 Aug; 158(2):263-269. PubMed ID: 35467000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
    Kojima Y; Ohtsuka K; Ohnishi H; Abe N; Furuse J; Watanabe T; Sugiyama M
    Surg Today; 2018 Aug; 48(8):765-772. PubMed ID: 29525853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification.
    Rooper LM; Argyris PP; Thompson LDR; Gagan J; Westra WH; Jordan RC; Koutlas IG; Bishop JA
    Am J Surg Pathol; 2021 Oct; 45(10):1337-1347. PubMed ID: 33739781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinoma of the urinary bladder.
    Dadhania V; Czerniak B; Guo CC
    Am J Clin Exp Urol; 2015; 3(2):51-63. PubMed ID: 26309895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation profile of high-grade appendiceal mucinous neoplasm.
    Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N
    Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Intestinal Metaplasia Without Dysplasia in the Urinary Bladder Reveal Only Rare Mutations Associated With Colorectal Adenocarcinoma.
    Amin A; Murati-Amador B; Lombardo KA; Jackson CL; Grada Z; Palsgrove DN; Matoso A
    Appl Immunohistochem Mol Morphol; 2020; 28(10):786-790. PubMed ID: 31876604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
    Lin MT; Zheng G; Tseng LH; Zhang P; Ling H; Azad N; Gocke CD; Montgomery E; Eshleman JR
    Hum Pathol; 2020 Apr; 98():120-128. PubMed ID: 32171651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.
    Munari G; Businello G; Mattiolo P; Pennelli G; Sbaraglia M; Borga C; Pucciarelli S; Spolverato G; Mescoli C; Galuppini F; Sommariva A; Bellan E; Lonardi S; Loupakis F; Luchini C; Dei Tos AP; Fassan M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1897-1904. PubMed ID: 33712927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.
    Almassi N; Whiting K; Toubaji A; Lenis AT; Jordan EJ; Won H; Regazzi AM; Chen YB; Gopalan A; Sirintrapun SJ; Fine SW; Tickoo SK; Ostrovnaya I; Pietzak EJ; Cha EK; Goh AC; Donahue TF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Teo MY; Funt SA; Rosenberg JE; Reuter VE; Bajorin DF; Solit DB; Al-Ahmadie H; Iyer G
    JCO Precis Oncol; 2022 Jun; 6():e2100392. PubMed ID: 35731998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
    Cowan ML; Springer S; Nguyen D; Taheri D; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; Del Carmen Rodriguez Pena M; VandenBussche CJ; Olson MT; Cunha I; Fujita K; Ertoy D; Kinzler K; Bivalacqua T; Papadopoulos N; Vogelstein B; Netto GJ
    Hum Pathol; 2016 Jul; 53():8-13. PubMed ID: 26980028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glandular Tumors of the Urachus and Urinary Bladder: A Practical Overview of a Broad Differential Diagnosis.
    Taylor AS; Mehra R; Udager AM
    Arch Pathol Lab Med; 2018 Oct; 142(10):1164-1176. PubMed ID: 30281367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
    Li X; Sun K; Liao X; Gao H; Zhu H; Xu R
    BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.